Brenda M Birmann

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Body mass index, physical activity, and risk of multiple myeloma
    Brenda M Birmann
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 16:1474-8. 2007
  2. ncbi Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica
    Brenda M Birmann
    Department of Epidemiology, Brigham and Women s Hospital and Harvard School of Public Health, Boston, MA 02115, USA
    Int J Cancer 124:614-21. 2009
  3. ncbi Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma
    Brenda M Birmann
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 18:282-8. 2009
  4. ncbi Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I
    Brenda M Birmann
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    J Med Virol 78:847-52. 2006
  5. ncbi Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women
    Eva S Schernhammer
    Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Am J Clin Nutr 96:1419-28. 2012
  6. ncbi Nutrients and genetic variation involved in one-carbon metabolism and Hodgkin lymphoma risk: a population-based case-control study
    Julie L Kasperzyk
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
    Am J Epidemiol 174:816-27. 2011
  7. ncbi A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma
    Kimberly A Bertrand
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115, USA
    Blood 116:3547-53. 2010
  8. ncbi Serologic assessment of type 1 and type 2 immunity in healthy Japanese adults
    Brenda M Birmann
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 13:1385-91. 2004
  9. ncbi Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis
    Nancy E Mueller
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Int J Cancer 130:2886-91. 2012
  10. ncbi Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium
    Brenda M Birmann
    Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Blood 120:4929-37. 2012

Research Grants

  1. Energy Balance, IGF Dysregulation and Multiple Myeloma
    Brenda Birmann; Fiscal Year: 2007

Detail Information

Publications10

  1. ncbi Body mass index, physical activity, and risk of multiple myeloma
    Brenda M Birmann
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 16:1474-8. 2007
    ..In conclusion, obesity seems to have an etiologic role in multiple myeloma, but the role of other correlates of energy balance remains uncertain...
  2. ncbi Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica
    Brenda M Birmann
    Department of Epidemiology, Brigham and Women s Hospital and Harvard School of Public Health, Boston, MA 02115, USA
    Int J Cancer 124:614-21. 2009
    ....
  3. ncbi Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma
    Brenda M Birmann
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 18:282-8. 2009
    ..Nonetheless, the data are consistent with the hypothesis that IGF-1- and IL-6-related gene variation influences susceptibility to multiple myeloma and warrant confirmation in larger populations...
  4. ncbi Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I
    Brenda M Birmann
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    J Med Virol 78:847-52. 2006
    ....
  5. ncbi Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women
    Eva S Schernhammer
    Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Am J Clin Nutr 96:1419-28. 2012
    ..Despite safety reports of the artificial sweetener aspartame, health-related concerns remain...
  6. ncbi Nutrients and genetic variation involved in one-carbon metabolism and Hodgkin lymphoma risk: a population-based case-control study
    Julie L Kasperzyk
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
    Am J Epidemiol 174:816-27. 2011
    ..Associations between diet and risk of Epstein-Barr virus-negative disease require confirmation in other populations...
  7. ncbi A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma
    Kimberly A Bertrand
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115, USA
    Blood 116:3547-53. 2010
    ..Overall, we found no evidence that EBV antibody profile predicts NHL risk in immunocompetent persons, with the possible exception of chronic lymphocytic leukemia/small lymphocytic lymphoma...
  8. ncbi Serologic assessment of type 1 and type 2 immunity in healthy Japanese adults
    Brenda M Birmann
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 13:1385-91. 2004
    ..We conclude that, with the exception of soluble CD30, the serologic markers are informative for the characterization of type 1/type 2 immune status using archived sera from study populations of healthy adults...
  9. ncbi Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis
    Nancy E Mueller
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Int J Cancer 130:2886-91. 2012
    ..EBNA antibodies were not significantly associated with IM history in HL cases or siblings. These associations suggest that chronic or more severe EBV infection is a risk factor for HL, independent of IM history...
  10. ncbi Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium
    Brenda M Birmann
    Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Blood 120:4929-37. 2012
    ....

Research Grants2

  1. Energy Balance, IGF Dysregulation and Multiple Myeloma
    Brenda Birmann; Fiscal Year: 2007
    ..Thus, the proposed project represents an innovative research project strategically designed to enhance the career development of the Candidate. ..